- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07419555
Belgische Longfunctie Studie (AIRCAST)
Belgische Longfunctiestudie: Gepersonaliseerde longitudinale longfunctieanalyse als marker voor ziekteprogressie
Currently, it remains unclear how to manage serial lung function measurements in a clinical setting. The investigators aimed to tackle this problem by developing a machine learning (ML) model that can accurately predict population and individual lung function trajectories. These predictions would enable the investigators to identify positive or negative deviations, thereby revealing unexpected disease patterns.
A prospective validation is needed that includes data on mortality, hospitalisations, emergency-room visits and patient-reported outcomes. Within this study, the goal is to validate the ML model with the data collected from this observational study.
Studie Overzicht
Toestand
Gedetailleerde beschrijving
The objective of this study is to explore the clinical value of models predicting longitudinal lung function patterns in individuals with chronic respiratory diseases across Belgium.
- The investigators will assess the accuracy of individualised lung function prediction models in a multicentre lung function dataset with prospective clinical and lung function follow-up.
- The investigators will evaluate important health outcomes, step-up in care, patient-reported outcomes in individuals identified with an expected and unexpected observed trajectory as compared to the predicted population and individualised trajectory.
The hypothesis is that patients with an unexpected decline in lung function will have worse health outcomes, such as a higher mortality rate and more hospitalisations, compared to patients with an expected lung function pattern. The investigators hypothesise to observe better health outcomes and lower mortality rates in patients with an unexpectedly positive lung function evolution compared to patients with an expected negative lung function pattern.
Individuals will be recruited from 4 Belgian Hospitals (UZ Leuven, UZ Antwerpen, AZ Delta, ZOL Genk). Based on the annual rate of pulmonary function testing in these hospitals, a sample size of 1.000 participants per centre is anticipated within one year of inclusions, resulting in a total sample size of 4.000 patients.
All available historical lung function data of included individuals will be retrieved from the individuals medical file. Additionally, the individual will be prospectively followed for 2 years where all lung function data will be collected.
Studietype
Inschrijving (Geschat)
Contacten en locaties
Studiecontact
- Naam: Marieke Wuyts
- Telefoonnummer: 016 34 31 59
- E-mail: marieke.wuyts@kuleuven.be
Studie Locaties
-
-
-
Edegem, België, 2650
- Werving
- UZ Antwerpen
-
Contact:
- Therese Lapperre
- Telefoonnummer: 0032 3 821 5089
- E-mail: therese.lapperre@uza.be
-
Hoofdonderzoeker:
- Therese Lapperre
-
Onderonderzoeker:
- Kevin De Soomer
-
Genk, België, 3600
- Werving
- Ziekenhuis Oost-Limburg
-
Contact:
- David Ruttens
- Telefoonnummer: 0032 89 80 52 00
- E-mail: david.ruttens@zol.be
-
Hoofdonderzoeker:
- David Ruttens
-
Onderonderzoeker:
- Maarten Criel
-
Ghent, België
- Werving
- UZ Gent
-
Hoofdonderzoeker:
- Eric Derom
-
Contact:
- Eric Derom
- Telefoonnummer: 0032 9 332 23 42
- E-mail: Eric.Derom@uzgent.be
-
Onderonderzoeker:
- Lies Lahousse
-
Leuven, België, 3000
- Werving
- UZ Leuven
-
Hoofdonderzoeker:
- Wim Janssens
-
Contact:
- Marieke Wuyts
- Telefoonnummer: 016 34 31 59
- E-mail: marieke.wuyts@kuleuvne.be
-
Roeselare, België, 8800
- Werving
- AZ Delta
-
Hoofdonderzoeker:
- Ingel Demedts
-
Contact:
- Ingel Demedts
- Telefoonnummer: 0032 51 23 41 16
- E-mail: ingel.demedts@azdelta.be
-
Onderonderzoeker:
- Bernard Bouckaert
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Chronic respiratory diseases
Beschrijving
Inclusion Criteria:
- Above 18 years old
- Diagnosed with a chronic respiratory disease and followed up in one of the participating Belgian hospitals
- Performed a complete lung function test (spirometry, body plethysmography and diffusion capacity) at baseline
- Have at least 3 historical spirometry measurements over a minimal time window of 2 years prior to inclusion
- Planned routine follow-up within standard clinical care in one of the participating hospitals
Exclusion Criteria:
- Patients who have had a lung transplantation
- Patients not being able to give consent to participate
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: COHORT
- Tijdsperspectieven: PROSPECTIVE
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Accuracy of lung function predictions (FEV1)
Tijdsspanne: at 1 and 2-year follow-up
|
Proportion of correct and incorrect FEV1 predictions compared to the observed measure |
at 1 and 2-year follow-up
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Differences in clinical outcomes between correct and incorrect lung function predictions (FEV1)
Tijdsspanne: at 1 and 2-year follow-up
|
Differences between patients with correct and incorrect individual lung function predictions for FEV1 on clinical endpoints (such as mortality, hospitalisations, frailty, health status and step-up in care |
at 1 and 2-year follow-up
|
|
Accuracy of lung function predictions
Tijdsspanne: at 1 and 2-year follow-up
|
Proportion of correct and incorrect lung function predictions (FVC, TLC, RV/TLC, DLCO) compared to the observed measure |
at 1 and 2-year follow-up
|
|
Differences in clinical outcomes between correct and incorrect lung function predictions
Tijdsspanne: at 1 and 2-year follow-up
|
Differences between patients with correct and incorrect individual lung function predictions for FVC, TLC, RV/TLC, DLCO on clinical endpoints (such as mortality, hospitalisations, frailty, health status and step-up in care) |
at 1 and 2-year follow-up
|
|
Identifying the minimal needed to make predictions
Tijdsspanne: after 2 years
|
Minimal number of tests/length of follow-up required for optimal predictions |
after 2 years
|
|
Performance of ML-based predictions compared to linear regression analysis
Tijdsspanne: at 1 and 2-year follow-up
|
Comparison of the ML-based predictions for individual and population lung function changes with predictions based on linear regression on individual historical data |
at 1 and 2-year follow-up
|
|
Overall description of population
Tijdsspanne: baseline, 1 and 2-year follow-up
|
Sociodemographic information, health status, comorbidities, frailty, disease labels, interventions and prognosis of individuals with a chronic respiratory disease |
baseline, 1 and 2-year follow-up
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Hoofdonderzoeker: Wim Janssens, UZ/KU Leuven
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Andere studie-ID-nummers
- S70923
- C2M25045 (Ander subsidie-/financieringsnummer: Internal funding KULeuven)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .